Biomarker development in COPD: moving from p-values to products to impact patient care Sin D, Hollander Z, DeMarco M, Sadatsafavi M, McManus BM, Ng, Raymond. CHESTA February 2017; 151(2):455-467. View paper bcregmed@admin2017-07-07T00:00:00-07:00July 7th, 2017|Categories: Research| Share This Event! FacebookTwitterLinkedInWhatsAppEmail Related Posts Cell competition during reprogramming gives rise to dominant clones Cell competition during reprogramming gives rise to dominant clones November 12th, 2019 | 0 Comments The optoelectronic microrobot: A versatile toolbox for micromanipulation The optoelectronic microrobot: A versatile toolbox for micromanipulation August 1st, 2019 | 0 Comments Soluble Wood Smoke Extract Promotes Barrier Dysfunction in Alveolar Epithelial Cells through a MAPK Signaling Pathway Soluble Wood Smoke Extract Promotes Barrier Dysfunction in Alveolar Epithelial Cells through a MAPK Signaling Pathway July 15th, 2019 | 0 Comments